Written by Taylor Woosley, Staff Writer. Findings of the prospective observational study show that risk factors such as dyslipidemia, atrial fibrillation, and smoking are strongly connected to fatty acids. Limiting or eliminating modifiable lifestyle risk factors such as smoking or alcohol consumption can positively influence the fatty-acids profile. (more…)
Written by Taylor Woosley, Staff Writer. Analyzing data from the NHANES 2003-2004 shows that US older adults with higher PLP levels was associated with a greater level of EPA, DHA, EPA + DHA, EPA/AA, and (EPA + DHA)/AA. The odds of having high plasma EPA (aOR: 2.03, P=0.049) and EPA/AA (aOR: 3.83, P<0.001) were greater in those with adequate B6 status compared to those with low B6 levels. (more…)
Written by Jessica Patella, ND. Study observations show an association between higher omega-3s, DHA and EPA and slower cognitive decline in patients with Alzheimer’s disease on acetylcholinesterase inhibitors. (more…)
Written by Taylor Woosley, Staff Writer. Participants following a 16-week diet focused on increasing EPA & DHA levels (designed to increase EPA&DHA to 1.5g/day) and either maintaining or reducing linoleic acid levels decreased the rate of occurrence and severity of chronic headaches. (more…)
Written by Joyce Smith, BS. Icosapent ethyl, a highly stable and purified formulation of EPA significantly reduced cardiovascular events and triglyceride levels in elderly patients with cardiovascular risk factors who were on statin therapy. (more…)
Written by Angeline A. De Leon, Staff Writer. Participants who supplemented with eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) had significantly greater reductions in circulating levels of proinflammatory cytokines compared with the control group. (more…)
Written by Jessica Patella, ND. Vitamin/mineral and fatty acid supplementation for 12 weeks significantly improved EPA/DHA levels in participating school-aged children compared to placebo.
Written by Greg Arnold, DC, CSCS. The 40 boys with Attention Deficit/Hyperactivity Disorder (ADHD), who supplemented with 650 mg of DHA and 650 mg of EPA for 16 weeks, had a 15.4% reduction in behavioral symptoms compared to 17.9% increase in the placebo group. (more…)
Written by Greg Arnold, DC, CSCS. Eight weeks of fish oil supplementation significantly decreased systolic blood pressure in those subjects with blood pressure readings of 145.8/81.1. This reflects a 20% decreased risk of cardiovascular disease.
(more…)
Written by Patrick B. Massey, MD, PhD. A study of 105 chronic migraine sufferers found that a diet rich in EPA and DHA may significantly reduce the incidence of migraine headaches. (more…)
Written by Jessica Patella, ND. A combination of omega-3 and omega-6 oil improved symptoms of dry eye, smoothness of the cornea and decreased eye discomfort. (more…)
